Effect of EphA2 Silencing on Inhibiting the Progression of Renal Cell Carcinoma in an Orthotopic Mouse Model
Taein Lee, Hye-Sun Lee, Sangjun Yoo, Hoyoung Bae, Min Chul Cho, Junghoon Lee, Hyeon Jeong, Alexander E Kalyuzhny · 2025
Read Effect of EphA2 Silencing on Inhibiting the Progression of Renal Cell Carcinoma in an Orthotopic Mouse Model by Taein Lee, Hye-Sun Lee, Sangjun Yoo, Hoyoung Bae, Min Chul Cho, Junghoon Lee, Hyeon Jeong, Alexander E Kalyuzhny (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12732110.txt.
Description
Taein Lee and co-authors test a gene-silencing strategy against kidney cancer in mice in a 2025 study. The target is EphA2, a receptor that helps tumor cells behave badly. The team grew kidney tumor cells with the gene knocked down and implanted them under the kidney capsule of mice, the organ's true site.
Tumors with the gene silenced grew far less than controls, weighed much less at harvest, and showed more cell death. Two partner signals that drive malignant behavior, FAK and RhoA, also quieted. The authors read the pathway as a promising drug target for renal cell carcinoma and call for work toward treatments that block it.
Catalog record
| CREATOR | Taein Lee, Hye-Sun Lee, Sangjun Yoo, Hoyoung Bae, Min Chul Cho, Junghoon Lee, Hyeon Jeong, Alexander E Kalyuzhny |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |